With reference to its earlier communication dated February 20, 2025, wherein the Company had informed the Stock Exchange regarding resignation of Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy of the Company, effective close of business hours of April 15, 2025, to pursue opportunities outside the Company. Further to the above communication and pursuant to Regulation 30 read with Clause 7C of Para A of Part A of Schedule Ill of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that it enclosed, resignation letter of Namita Shah.
The above information is a part of company’s filings submitted to BSE.
